Goldman Sachs is in the spotlight as tech firms Arm and Instacart test IPO market

France Nouvelles Nouvelles

Goldman Sachs is in the spotlight as tech firms Arm and Instacart test IPO market
France Dernières Nouvelles,France Actualités
  • 📰 NBCNewYork
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 63%

The drought in tech IPOs the past 18 months is about to break — and it’s a key moment for leading advisor Goldman Sachs.

initially to the roughly $55 billion that represents the top end of a target share price of $47 to $51.

Further, Arm is selling an unusually small slice of its overall stock, about 9%, which helps drive scarcity. That small public float means new investors will have fewer rights related to voting power and corporate governance, Trainer noted.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NBCNewYork /  🏆 270. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Can Arm and Instacart Resuscitate the IPO Market?Can Arm and Instacart Resuscitate the IPO Market?Stocks Analysis by Christine Short covering: Campbell Soup Company, Hostess Brands Inc, Klaviyo Inc. Read Christine Short's latest article on Investing.com
Lire la suite »

Goldman Sachs is in the spotlight as tech firms test IPO marketGoldman Sachs is in the spotlight as tech firms test IPO marketThe drought in tech IPOs the past 18 months is about to break — and it’s a key moment for leading advisor Goldman Sachs.
Lire la suite »

Goldman Sachs asset and wealth management executive to retire, as others join firmGoldman Sachs asset and wealth management executive to retire, as others join firmGoldman Sachs Group Inc. executive Laurence Stein is retiring after 27 years at the bank, according to an internal memo seen by MarketWatch. Stein was most...
Lire la suite »

Goldman Sachs discloses short position in Philips after Dutch regulator review By ReutersGoldman Sachs discloses short position in Philips after Dutch regulator review By ReutersGoldman Sachs discloses short position in Philips after Dutch regulator review
Lire la suite »

Hedge funds have bailed on the U.S. consumer in a big way, Goldman Sachs data findsHedge funds have bailed on the U.S. consumer in a big way, Goldman Sachs data findsHedge funds are betting that the U.S. consumer is in for a difficult ride.
Lire la suite »

Goldman Sachs says this blood cancer treatment stock can gain 70% ahead of planned drug launchGoldman Sachs says this blood cancer treatment stock can gain 70% ahead of planned drug launchAnalyst Corinne Jenkins upgraded the firm to buy from neutral and maintained her price target of $4.
Lire la suite »



Render Time: 2025-03-03 13:28:06